HyClone covers cell culture, gene modulation and magnetic beads. GE Healthcare officials expect the acquisition will expand its life sciences business.
Terms of the deal were not disclosed. The transaction was first announced in January.
More Articles on GE Healthcare:
GE Healthcare Recalls Infant Resuscitation Systems
GE Healthcare Expands Technology Offerings
New Mississippi Program to Connect Rural Diabetics with Specialists via Telehealth
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
